Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-04

Clinical Trial Update: Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating aspirin for prevention of colorectal cancer in people with colorectal adenoma. Results have been posted as of 2025-03-04,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Adenoma, Colorectal Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-03-04